Effects of Combined Artemisia absinthium and Temozolomide Treatment on Apoptosis, Autophagy, and Nitric Oxide Synthase in Glioblastoma
Open Access
- 13 February 2026
- journal article
- Published by Commagene Journal of Biology in Commagene Journal of Biology
- Vol. 10 (1)
Abstract
Artemisia absinthium (wormwood; WO) is a plant known for its anticancer potential and this study comprehensively evaluates the effects of WO, alone and in combination with Temozolomide (TMZ), on cytotoxicity, apoptosis, autophagy, mitochondrial membrane potential, cell migration, and nitric oxide synthase (NOS) responses in T98-G glioblastoma cells. Cytotoxicity, apoptosis, autophagy, mitochondrial membrane potential, and cell migration were assessed using MTT, Annexin V-FITC/PI, JC-1, monodansylcadaverine (MDC) staining, and wound healing assay, respectively. Protein levels of eNOS, iNOS, and LC3-II were examined using immunofluorescence and western blotting. WO significantly reduced T98-G cell viability in a dose- and time-dependent manner with pronounced cytotoxicity observed at 48 and 72 hours. The combined treatment increased early (24.6%) and late (40.5%) apoptosis, reducing cell viability to 31.9%. Combined treatment markedly increased autophagic vacuoles, enhancing perinuclear and cytoplasmic accumulation compared with single agents. Combined WO and TMZ treatment disrupted mitochondrial membrane potential more prominently than either agent alone, suggesting that apoptosis is mediated via the mitochondrial pathway. WO strongly inhibited T98-G cell migration, whereas TMZ and the combination had moderate suppressive effects. In T98-G cells, WO IC₅₀ significantly increased eNOS (p<0.0001), iNOS (p<0.0001), and LC3 (p<0.01), while TMZ IC₅₀ moderately increased iNOS (p<0.05) and combined treatment maximally elevated iNOS and LC3 (p<0.0001) without further affecting eNOS. Preliminary Western blot analyses qualitatively corroborated the immunofluorescence data, indicating consistent treatment-dependent trends in eNOS, iNOS, and LC3-II expression. These findings highlight the potential of WO in enhancing TMZ efficacy and provide a basis for further investigation in glioblastoma therapy.Keywords
Funding Information
- Manisa Celal Bayar University. Scientific Research Projects Committee. (2022-025)
This publication has 17 references indexed in Scilit:
- Umbelliprenin induces autophagy and apoptosis while inhibits cancer cell stemness in pancreatic cancer cellsCancer Medicine, 2023
- Natural product-based nanoformulations for cancer therapy: Opportunities and challengesSeminars in Cancer Biology, 2021
- Methanolic extract of Artemisia absinthium prompts apoptosis, enhancing expression of Bax/Bcl-2 ratio, cell cycle arrest, caspase-3 activation and mitochondrial membrane potential destruction in human colorectal cancer HCT-116 cellsMolecular Biology Reports, 2020
- Cytotoxic potential of Artemisia absinthium extract loaded polymeric nanoparticles against breast cancer cells: Insight into the protein targetsInternational Journal of Pharmaceutics, 2020
- Evaluation of anticancer, antioxidant activity and phenolic compounds of Artemisia absinthium L. ExtractCellular and Molecular Biology, 2018
- Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature ReviewCurrent Medicinal Chemistry, 2017
- Glial cells in (patho)physiologyJournal of Neurochemistry, 2012
- Neuroprotective effect of Artemisia absinthium L. on focal ischemia and reperfusion-induced cerebral injuryJournal of Ethnopharmacology, 2010
- In vitro antiplasmodial and phytochemical study of five Artemisia species from Iran and in vivo activity of two speciesParasitology Research, 2010
- Comparison of the effects of Artemisia vulgaris and Artemisia absinthium growing in western Anatolia against trichinellosis (Trichinella spiralis) in ratsExperimental Parasitology, 2008